Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_assertion description "[Sequencing of bisulfite-modified DNA within a 3,247 bp long genomic region encompassing the promoter/first exon CpG island, the coding sequence of the S100A6 gene and a downstream region showed that it is almost entirely methylation-free in S100A6 expressing human epidermoid carcinoma (Hep-2) cells and lymphocytes and methylated in S100A6-negative embryonic epithelial (HEK293) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_assertion evidence source_evidence_literature NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_assertion SIO_000772 17495951 NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_assertion wasDerivedFrom befree-20150227 NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_assertion wasGeneratedBy ECO_0000203 NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.